Chapter 8. Syncope and the Implantable Cardioverter Defibrillator

  1. Blair P. Grubb MD1 and
  2. Brian Olshansky MD2
  1. Brian Olshansky MD

Published Online: 16 NOV 2007

DOI: 10.1002/9780470994801.ch8

Syncope: Mechanisms and Management, Second Edition

Syncope: Mechanisms and Management, Second Edition

How to Cite

Olshansky, B. (2005) Syncope and the Implantable Cardioverter Defibrillator, in Syncope: Mechanisms and Management, Second Edition (eds B. P. Grubb and B. Olshansky), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470994801.ch8

Editor Information

  1. 1

    Professor of Medicine and Pediatrics Director, Cardiac Electrophysiology Section Medical College of Ohio Toledo, OH

  2. 2

    Professor of Medicine Director, Cardiac Electrophysiology University of Iowa Medical Center Iowa City, IA

Publication History

  1. Published Online: 16 NOV 2007
  2. Published Print: 26 MAY 2005

ISBN Information

Print ISBN: 9781405122078

Online ISBN: 9780470994801

SEARCH

Keywords:

  • syncope;
  • ventricular arrhythmia;
  • cardioverter defibrillator;
  • implantable cardioverter defibrillators;
  • left ventricular ejection fraction

Summary

This chapter contains sections titled:

  • Introduction

  • Methods to identify risk - who is at highest risk of sudden cardiac death?

  • Is syncope an independent predictor of death?

  • Reducing chance of death in syncope patients at risk of sudden and cardiovascular death

  • ICDs

  • When to consider an ICD in a syncope patient

  • Electrophysiologic testing

  • Syncope of undetermined origin

  • What to do before the ICD implant

  • Specific subgroups

  • Disadvantages of ICDs

  • Conclusions